Sagimet Biosciences News

Piper Sandler Sticks to Its Buy Rating for Sagimet Biosciences, Inc. Class A (SGMT)

TipRanksMay 29 07:06 ET

Buy Rating Justified: Sagimet Biosciences' Undervalued Market Position and Promising NASH Treatment Potential

TipRanksMay 29 00:35 ET

Sagimet Biosciences Analyst Ratings

BenzingaMay 24 06:33 ET

Buy Rating Affirmed for Sagimet Biosciences on Promising NASH Treatment Potential

TipRanksMay 24 00:35 ET

Sagimet Biosciences Analyst Ratings

BenzingaMay 16 06:30 ET

Sagimet Biosciences: Strong Buy Rating on Robust Financials and Promising NASH Treatment Trials

TipRanksMay 15 19:45 ET

Sagimet Biosciences Analyst Ratings

BenzingaMay 2 06:54 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Alkermes (ALKS)

TipRanksMay 2 06:32 ET

Sagimet Biosciences Analyst Ratings

BenzingaMar 26 12:53 ET

Sagimet Biosciences Analyst Ratings

BenzingaMar 25 06:45 ET

Leerink Partners Initiates Coverage On Sagimet Biosciences With Outperform Rating, Announces Price Target of $26

BenzingaMar 25 06:46 ET

Analysts Offer Insights on Healthcare Companies: Rockwell Med (RMTI), Hookipa Pharma (HOOK) and Sagimet Biosciences, Inc. Class A (SGMT)

TipRanksMar 25 06:30 ET

Sagimet Biosciences Analyst Ratings

BenzingaFeb 7 11:22 ET

Buy Rating Affirmed for Sagimet Biosciences as Phase 2b Results of Denifanstat Outshine Competitors

TipRanksFeb 6 16:05 ET

Sagimet Biosciences Analyst Ratings

BenzingaJan 23 09:08 ET

JMP Securities Reiterates Market Outperform on Sagimet Biosciences, Maintains $31 Price Target

BenzingaDec 5, 2023 09:27 ET

Sagimet Biosciences Analyst Ratings

BenzingaDec 5, 2023 09:25 ET

Analysts Offer Insights on Healthcare Companies: BioAtla (BCAB), Gamida Cell (GMDA) and Sagimet Biosciences, Inc. Class A (SGMT)

TipRanksDec 5, 2023 00:51 ET

Sagimet Biosciences: Promising Financial Outlook and FASN Inhibitor Trial Progress Bolster Buy Rating

TipRanksNov 17, 2023 10:16 ET

Sagimet Biosciences, Inc. Class A (SGMT) Gets a Buy From Piper Sandler

TipRanksOct 17, 2023 09:27 ET